YANKCOM Partnership »

Travere Therapeutics shares owned by YANKCOM Partnership

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by YANKCOM Partnership from 13F filings

Historical chart of YANKCOM Partnership investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by YANKCOM Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by YANKCOM Partnership

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8k 100 38.21

More positions owned by YANKCOM Partnership

Vanguard FTSE Developed Markets ETF Van Ftse Dev Mkt (VEA)
Vanguard Index Funds S&P 500 ETF S&p 500 Etf Shs (VOO)
Schwab Strategic Tr US Large-Cap Value ETF Us Lcap Va Etf (SCHV)
iShares Tr S&P Midcap 400 ETF Core S&p Mcp Etf (IJH)
iShares Tr Russell Top 200 Growth ETF Rus Tp200 Gr Etf (IWY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Cap Stock Cl A Cap Stk Cl A (GOOGL)
Vanguard FTSE Emerging Markets ETF Ftse Emr Mkt Etf (VWO)
SPDR Portfolio Developed World Ex-US ETF Portfolio Devlpd (SPDW)
Citigroup Com New (C)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)

View all positions for YANKCOM Partnership

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics